Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Phosphoric Acid | HCID 1004 | — |
| Reactant | Tetrahydrofuran | HCID 8028 | — |
| Reactant | HCID 178474856 | HCID 178474856 | — |
| Solvent | Isopropanol | HCID 3776 | — |
| Product | HCID 178474858 | HCID 178474858 | — |
Reaction Steps
To a stirred suspension of N-{[(5S)-3-(2-fluoro-4′-{[(1H-1,2,3-triazol-5-ylmethyl)amino]methyl}biphenyl-4-yl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide (50.69 mg, 0.116 mmol) in isopropanol (1.0 mL) was added 0.5 M phosphoric acid in isopropanol (0.7 mL, 0.35 mmol), and the resulting mixture stirred at room temperature for 20 min. The resulting stirred suspension was heated to 80° C. and then concentrated under reduced pressure to give a solid. The solid was treated with aqueous tetrahydrofuran, stirred, and concentrated under reduced pressure to give the title compound as an amorphous solid which was characterized by XRPD. FIG. 5 shows a characteristic X-ray powder diffraction (XRPD) pattern of amorphous N-{[(5S)-3-(2-fluoro-4′-{[(1H-1,2,3-triazol-5-ylmethyl)amino]methyl}biphenyl-4-yl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide monophosphate.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09126991B2 |
|---|
| Source dataset | uspto-grants-2015_09 |
|---|
| ORD ID | ord-477fc1e798c74874a2655673fd5d7aff |
|---|
| Source note | uspto-grants-2015_09 |
|---|